NEW MJ NEWS

Cronos Group, Inc. to Host Earnings Call

Cronos Group, Inc. (NASDAQ:CRON) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on November 5, 2020 at 8:30 AM Eastern Time.

To listen to the event live or access a replay of the call – visit
https://www.investornetwork.com/event/presentation/70536

To receive updates for this company you can register by emailing info@investornetwork.com or by clicking get investment info from the company’s profile.

– ADVERTISEMENT –

About Investor Network

Investor Network (IN) is a financial content community, serving millions of unique investors market information, earnings, commentary and news on what’s trending. Dedicated to both the professional and the average traders, IN offers timely, trusted and relevant financial information for virtually every investor. IN is an Issuer Direct brand, to learn more or for the latest financial news and market information, visit www.investornetwork.com. Follow us on Twitter @investornetwork.

SOURCE: Investor Network

View source version on accesswire.com:
https://www.accesswire.com/614632/Cronos-Group-Inc-to-Host-Earnings-Call


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Emblem Corp. (EMMBF) signs five-year supply agreement with Compass Cannabis Clinic for Starbuds Canada

Emblem signs five-year supply agreement with Compass Cannabis Clinic for Starbuds Canada…

Tauriga Sciences, Inc. (TAUG) Confirms Canadian Trading Halt Lifted at Open of Market on November 1, 2017

Tauriga Sciences, Inc. Confirms Canadian Trading Halt Lifted at Open of Market…

Blue Line Protection Group, Inc. (BLPG) Names Christopher E. Galvin as New Chairman of Board of Directors

Blue Line Protection Group Names Christopher E. Galvin as New Chairman of…

$CARA Positive Data From Quantitative Phase 1 Trial

Cara Therapeutics Announces Positive Data From Quantitative Phase 1 Trial Measuring Respiratory…